agilon health, inc.
AGL
$86.39
$5.827.22%
NYSE
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -9.47% | 9.39% | |||
| Total Other Revenue | -23.71% | -13.14% | |||
| Total Revenue | -9.50% | 9.35% | |||
| Cost of Revenue | -18.35% | 10.46% | |||
| Gross Profit | 171.71% | -34.04% | |||
| SG&A Expenses | -18.12% | 12.77% | |||
| Depreciation & Amortization | -2.61% | -6.20% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -18.28% | 10.46% | |||
| Operating Income | 106.46% | -22.97% | |||
| Income Before Tax | 115.97% | -69.68% | |||
| Income Tax Expenses | -97.89% | 500.00% | |||
| Earnings from Continuing Operations | 115.84% | -71.39% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 125.90% | -71.39% | |||
| EBIT | 106.46% | -22.97% | |||
| EBITDA | 111.07% | -27.49% | |||
| EPS Basic | 125.88% | -71.33% | |||
| Normalized Basic EPS | 124.00% | -40.99% | |||
| EPS Diluted | 125.82% | -71.33% | |||
| Normalized Diluted EPS | 123.91% | -40.99% | |||
| Average Basic Shares Outstanding | 0.09% | 0.04% | |||
| Average Diluted Shares Outstanding | 0.47% | 0.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||